000 | 02035ngm a2200481 a 4500 | ||
---|---|---|---|
001 | HST4015 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 150610s2015 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 |
_a4015 _bHenry Stewart Talks |
035 | _a(UkLoHST)3054 | ||
040 |
_aUkLoHST _beng _cUkLoHST |
||
100 | 1 |
_aGerson, Donald F. _u(PnuVax, Inc, CA) _4spk |
|
245 | 1 | 0 |
_aVaccine manufacturing _h[electronic resource] : _bpart 2 of 2 / _cDonald F. Gerson. |
246 | 3 | _aVaccine manufacturing, part 2, new processes for new vaccines | |
260 |
_aLondon : _bHenry Stewart Talks, _c2015. |
||
300 |
_a1 online resource (1 streaming video file (39 min.) : _bcolor, sound). |
||
490 | 1 |
_aVaccines : principles, recent developments and future directions, _x2056-452X |
|
500 | _aAnimated audio-visual presentation with synchronized narration. | ||
500 | _aTitle from title frames. | ||
505 | 0 | _aContents: New vaccines & the need for up-to-date technology -- Considerations for manufacturing facilities -- Quality systems (The mechanism for regulatory compliance) -- Large scale, routine manufacturing -- Warehousing and distribution of vaccine product. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 0 | _aVaccines industry. | |
650 | 0 |
_aVaccines _xBiotechnology. |
|
650 | 0 |
_aVaccines _xDevelopment. |
|
650 | 0 |
_aVaccines _xResearch. |
|
650 | 2 | _aBiomedical Research. | |
650 | 2 |
_aBiotechnology _xmethods. |
|
650 | 2 | _aDrug Design. | |
650 | 2 | _aDrug Discovery. | |
650 | 2 | _aHealth Services Needs and Demand. | |
650 | 2 | _aTechnology Transfer. | |
650 | 2 |
_aVaccines _xeconomics. |
|
650 | 2 |
_aVaccines _xisolation & purification. |
|
650 | 2 |
_aVaccines _xstandards. |
|
650 | 2 |
_aVaccines _xsupply & distribution. |
|
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pVaccines. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/3054/ |
856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/923/ _3Series |
999 |
_c76884 _d76884 |